Namely, PCA showed grouping cardiometabolic and redox status parameters according to equal variability in several factors, i.e., pro-oxidant-dyslipidemia-related factor (i.e., AOPP, TG, and TOS), hepatic steatosis-related factor (i.e., ALT and AST), and antioxidant-renal function-related factor (i.e., uric acid, creatinine, and TAS). The gene discussed is GPT; the disease is fatty liver disease.